Collegium Pharma (COLL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2022 | 03-2022 | 12-2021 | 09-2021 | 06-2021 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 122,722 | 106,698 | 186,426 | 193,241 | 202,771 |
| Receivables | 197,505 | 166,345 | 105,844 | 148,999 | 90,098 |
| Inventories | 77,769 | 80,146 | 17,394 | 17,358 | 19,595 |
| TOTAL | $409,774 | $363,638 | $315,543 | $363,238 | $318,532 |
| Non-Current Assets | |||||
| PPE Net | 19,965 | 20,202 | 19,491 | 19,629 | 19,555 |
| Intangibles | 777,393 | 826,311 | 268,723 | 285,518 | 302,314 |
| Other Non-Current Assets | 38,442 | 35,990 | 88,320 | 73,418 | 73,334 |
| TOTAL | $835,800 | $882,503 | $376,534 | $378,565 | $395,203 |
| Total Assets | $1,245,574 | $1,246,141 | $692,077 | $741,803 | $713,735 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 120,833 | 100,000 | 48,353 | 48,135 | 47,919 |
| Accounts payable and accrued liabilities | 6,627 | 3,851 | 4,189 | 7,730 | 7,543 |
| Accrued Expenses | 286,423 | 268,544 | 226,210 | 212,315 | 170,610 |
| TOTAL | $415,094 | $373,573 | $279,566 | $268,973 | $226,843 |
| Non-Current Liabilities | |||||
| Long Term Debt | 484,853 | 528,390 | 61,666 | 73,832 | 85,944 |
| Other Non-Current Liabilities | 148,015 | 148,102 | 147,917 | 147,904 | 147,882 |
| TOTAL | $632,868 | $676,492 | $209,583 | $221,736 | $233,826 |
| Total Liabilities | $1,047,962 | $1,050,065 | $489,149 | $490,709 | $460,669 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 34,126 | 33,973 | 33,378 | 34,569 | 35,564 |
| Common Shares | 37 | 36 | 36 | 36 | 36 |
| Retained earnings | -274,602 | -269,411 | -256,342 | -231,308 | -239,354 |
| Other shareholders' equity | 139 | 139 | 139 | -480 | 0 |
| TOTAL | $197,612 | $196,076 | $202,928 | $251,094 | $253,066 |
| Total Liabilities And Equity | $1,245,574 | $1,246,141 | $692,077 | $741,803 | $713,735 |